AV
Avai Bio, Inc.
AVAI · OTC
$0.15 +6.91% (+$0.01)
1M +19.40%
Market Cap $19.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.09
40.0% downside
Current Price
$0.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVAI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 229.11%
Asset turnover 0.00x
ROIC 151.49%
Debt
0 /100
High Int. coverage -13.74x
Current ratio 0.04x
Net debt/EBITDA N/A
Stability
38 /100
Moderate EPS volatility 117.23%
Profitable years 0
Beta 0.87x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVAI
Online
Sector
Technology
Industry
Software - Application
CEO
Chris Winter
Employees
1
Headquarters
Vilnius